Cargando…
ABO blood groups and the risk of SARS-CoV-2 infection
There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public inte...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Vienna
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973646/ https://www.ncbi.nlm.nih.gov/pubmed/35364749 http://dx.doi.org/10.1007/s00709-022-01754-1 |
_version_ | 1784680083184680960 |
---|---|
author | Bullerdiek, Jörn Reisinger, Emil Rommel, Birgit Dotzauer, Andreas |
author_facet | Bullerdiek, Jörn Reisinger, Emil Rommel, Birgit Dotzauer, Andreas |
author_sort | Bullerdiek, Jörn |
collection | PubMed |
description | There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public interest. It was postulated that blood group A predisposes to a higher risk of infection as well as to a much higher risk of severe respiratory disease and that people with blood group O are less frequently and less severely affected by the disease. However, as to the severity of COVID-19, a thorough summary of the existing literature does not support these assumptions in general. Accordingly, at this time, there is no reason to suppose that knowledge of a patient’s ABO phenotype should directly influence therapeutical decisions in any way. On the other hand, there are many data available supporting an association between the ABO blood groups and the risk of contracting SARS-CoV-2. To explain this association, several interactions between the virus and the host cell membrane have been proposed which will be discussed here. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00709-022-01754-1. |
format | Online Article Text |
id | pubmed-8973646 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Vienna |
record_format | MEDLINE/PubMed |
spelling | pubmed-89736462022-04-01 ABO blood groups and the risk of SARS-CoV-2 infection Bullerdiek, Jörn Reisinger, Emil Rommel, Birgit Dotzauer, Andreas Protoplasma Review There is no doubt that genetic factors of the host play a role in susceptibility to infectious diseases. An association between ABO blood groups and SARS-CoV-2 infection as well as the severity of COVID-19 has been suggested relatively early during the pandemic and gained enormously high public interest. It was postulated that blood group A predisposes to a higher risk of infection as well as to a much higher risk of severe respiratory disease and that people with blood group O are less frequently and less severely affected by the disease. However, as to the severity of COVID-19, a thorough summary of the existing literature does not support these assumptions in general. Accordingly, at this time, there is no reason to suppose that knowledge of a patient’s ABO phenotype should directly influence therapeutical decisions in any way. On the other hand, there are many data available supporting an association between the ABO blood groups and the risk of contracting SARS-CoV-2. To explain this association, several interactions between the virus and the host cell membrane have been proposed which will be discussed here. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00709-022-01754-1. Springer Vienna 2022-04-01 2022 /pmc/articles/PMC8973646/ /pubmed/35364749 http://dx.doi.org/10.1007/s00709-022-01754-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Review Bullerdiek, Jörn Reisinger, Emil Rommel, Birgit Dotzauer, Andreas ABO blood groups and the risk of SARS-CoV-2 infection |
title | ABO blood groups and the risk of SARS-CoV-2 infection |
title_full | ABO blood groups and the risk of SARS-CoV-2 infection |
title_fullStr | ABO blood groups and the risk of SARS-CoV-2 infection |
title_full_unstemmed | ABO blood groups and the risk of SARS-CoV-2 infection |
title_short | ABO blood groups and the risk of SARS-CoV-2 infection |
title_sort | abo blood groups and the risk of sars-cov-2 infection |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8973646/ https://www.ncbi.nlm.nih.gov/pubmed/35364749 http://dx.doi.org/10.1007/s00709-022-01754-1 |
work_keys_str_mv | AT bullerdiekjorn abobloodgroupsandtheriskofsarscov2infection AT reisingeremil abobloodgroupsandtheriskofsarscov2infection AT rommelbirgit abobloodgroupsandtheriskofsarscov2infection AT dotzauerandreas abobloodgroupsandtheriskofsarscov2infection |